Search Results - "Juanmin, Zha"
-
1
Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression
Published in Gastroenterology (New York, N.Y. 1943) (01-11-2019)“…Epithelial tight junctions are compromised in gastrointestinal disease. Processes that contribute to the resulting barrier loss include endocytic occludin…”
Get full text
Journal Article -
2
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Published in Nature medicine (01-04-2019)“…Epithelial barrier loss is a driver of intestinal and systemic diseases. Myosin light chain kinase (MLCK) is a key effector of barrier dysfunction and a…”
Get full text
Journal Article -
3
Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue
Published in Diabetes (New York, N.Y.) (01-02-2015)“…Long-term glucocorticoid (GC) treatment induces central fat accumulation and metabolic dysfunction. We demonstrate that microRNA-27b (miR-27b) plays a central…”
Get full text
Journal Article -
4
Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux
Published in Molecular biology of the cell (01-10-2013)“…In vitro and in vivo studies implicate occludin in the regulation of paracellular macromolecular flux at steady state and in response to tumor necrosis factor…”
Get full text
Journal Article -
5
TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells
Published in Molecular medicine reports (01-07-2019)“…Hypermethylation of transcription factor activating enhancer‑binding protein 2e (TFAP2E) has been reported to be associated with chemoresistance to…”
Get full text
Journal Article -
6
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
Published in Cell death & disease (21-01-2023)“…Osteosarcoma is the most common primary malignant bone tumour in children and adolescents. Chemoresistance leads to poor responses to conventional therapy in…”
Get full text
Journal Article -
7
BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice
Published in PloS one (02-07-2012)“…Inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is being pursued as a new therapeutic approach for the treatment of obesity and metabolic…”
Get full text
Journal Article -
8
11β-hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction
Published in Endocrine Journal (2013)“…Pharmacologic glucocorticoids (GCs) inhibit osteoblast function and induce osteoporosis. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) may play a role in…”
Get full text
Journal Article -
9
Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
Published in Endocrine Journal (2011)“…Current pharmacological treatments for obesity and metabolic syndrome have various limitations. Recently, adipose tissue 11β-hydroxysteroid dehydrogenase type…”
Get full text
Journal Article -
10
One-Step Construction of Lentiviral Reporter Using Red-Mediated Recombination
Published in Molecular biotechnology (01-11-2011)“…Current approaches to generate lentiviral vectors, which have been used extensively for gene therapy, are time consuming and require a large expenditure. Here,…”
Get full text
Journal Article -
11
11β-hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction
Published in ENDOCRINE JOURNAL (01-09-2013)“…[Abstract. ] Pharmacologic glucocorticoids (GCs) inhibit osteoblast function and induce osteoporosis. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) may…”
Get full text
Journal Article -
12
Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation
Published in Experimental and therapeutic medicine (01-07-2010)“…Studies on the relationship between obesity and bone have recently become widespread. The aim of this study was to investigate the effect of obesity on bone,…”
Get full text
Journal Article -
13
Adipose tissue-targeted 11.BETA.-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
Published in Endocrine journal (2011)Get full text
Journal Article -
14
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan
Published in Oncogene (27-10-2023)“…Chemotherapy resistance represents a major cause of therapeutic failure and mortality in cancer patients. Mesenchymal stromal cells (MSCs), an integral…”
Get full text
Journal Article -
15
Mechanisms underlying distinct subcellular localization and regulation of epithelial long myosin light-chain kinase splice variants
Published in The Journal of biological chemistry (01-02-2024)“…Intestinal epithelia express two long myosin light-chain kinase (MLCK) splice variants, MLCK1 and MLCK2, which differ by the absence of a complete…”
Get full text
Journal Article -
16
Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
Published in ENDOCRINE JOURNAL (2011)“…[Abstract.] Current pharmacological treatments for obesity and metabolic syndrome have various limitations. Recently, adipose tissue 11β-hydroxysteroid…”
Get full text
Journal Article -
17
Tu1831 MYPT1 Is a Critical Regulator of Intestinal Epithelial Cell Survival
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2016)Get full text
Journal Article -
18
Identification and characterization of the domain that mediates actin binding and directs basal and TNF‐induced myosin light chain kinase 1 (MLCK1) recruitment to the perijunctional actomyosin ring
Published in The FASEB journal (01-05-2022)“…Two myosin light chain kinase (MLCK) splice variants are expressed within intestinal epithelial cells, MLCK1 and MLCK2. These differ by a single exon that…”
Get full text
Journal Article -
19
Selective Inhibition of 11[beta]-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice
Published in Drug design, development and therapy (31-05-2021)“…Introduction: The effect of 11[beta]-hydroxysteroid dehydrogenase type1 (11[beta]-HSD1) inhibition on hepatic steatosis is incompletely understood. Here, we…”
Get full text
Journal Article -
20
Mechanisms underlying distinct subcellular localizations and regulation of epithelial long myosin light chain kinase (MLCK) splice variants
Published in The Journal of biological chemistry (08-01-2024)“…Intestinal epithelia express two long myosin light chain kinase (MLCK) splice variants, MLCK1 and MLCK2 that differ by the absence of a complete…”
Get full text
Journal Article